DMAA Drugs Made In America Acquisition Corp.
Nasdaq · SEC CIK 2028614 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 8 since 2025-02-03, latest 2025-02-18
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 12
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-18 | 2025-02-18 | DMAA | Drugs Made In America Acquisition LLC | 10% | P - Purchase | — | +30.0K | 4.19M | +0.7% | — |
| DI | 2025-02-18 | 2025-02-18 | DMAA | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | P - Purchase | — | +30.0K | 4.19M | +0.7% | — |
| D | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition LLC | 10% | P - Purchase | — | +400.0K | 10.26M | +4% | — |
| D | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition LLC | 10% | S - Sale | — | -5.70M | 4.16M | -58% | — |
| D | 2025-02-04 | 2025-01-29 | DMAA | Drugs Made In America Acquisition LLC | 10% | J - Other | — | -400.0K | 9.86M | -4% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Stockwell Lynn | CEO, Executive COB, Dir, 10% | S - Sale | — | -5.70M | 4.16M | -58% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Stockwell Lynn | CEO, Executive COB, Dir, 10% | J - Other | — | -400.0K | 9.86M | -4% | — |
| DI | 2025-02-04 | 2025-01-29 | DMAA | Stockwell Lynn | CEO, Executive COB, Dir, 10% | P - Purchase | — | +400.0K | 10.3K | New | — |
| 2025-02-03 | 2025-01-29 | DMAA | Worman Glenn C. | CFO | J - Other | — | +100.0K | 100.0K | New | — | |
| 2025-02-03 | 2025-01-29 | DMAA | Do Catherine | Dir | J - Other | — | +100.0K | 100.0K | New | — | |
| 2025-02-03 | 2025-01-29 | DMAA | Shulgan Myron W. | Dir | J - Other | — | +100.0K | 100.0K | New | — | |
| 2025-02-03 | 2025-01-29 | DMAA | Prasad Sridhar G. | Dir | J - Other | — | +100.0K | 100.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations